BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20065959)

  • 1. Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats.
    Lenard NR; Zheng H; Berthoud HR
    Int J Obes (Lond); 2010 Jun; 34(6):1001-10. PubMed ID: 20065959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu opioid receptor antagonism in the nucleus accumbens shell blocks consumption of a preferred sucrose solution in an anticipatory contrast paradigm.
    Katsuura Y; Taha SA
    Neuroscience; 2014 Mar; 261():144-52. PubMed ID: 24342569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens.
    Shin AC; Pistell PJ; Phifer CB; Berthoud HR
    Neuroscience; 2010 Oct; 170(2):580-8. PubMed ID: 20654704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
    Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
    Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats.
    Cole JL; Leventhal L; Pasternak GW; Bowen WD; Bodnar RJ
    Brain Res; 1995 Apr; 678(1-2):168-76. PubMed ID: 7620885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions.
    Bodnar RJ; Glass MJ; Ragnauth A; Cooper ML
    Brain Res; 1995 Nov; 700(1-2):205-12. PubMed ID: 8624711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food.
    Ward HG; Simansky KJ
    Psychopharmacology (Berl); 2006 Sep; 187(4):435-46. PubMed ID: 16847679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gamma-Aminobutyric acid receptor subtype antagonists differentially alter opioid-induced feeding in the shell region of the nucleus accumbens in rats.
    Znamensky V; Echo JA; Lamonte N; Christian G; Ragnauth A; Bodnar RJ
    Brain Res; 2001 Jul; 906(1-2):84-91. PubMed ID: 11430864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake.
    Pritchett CE; Pardee AL; McGuirk SR; Will MJ
    Brain Res; 2010 Jan; 1306():85-92. PubMed ID: 19822132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitatory amino acid receptor subtype agonists induce feeding in the nucleus accumbens shell in rats: opioid antagonist actions and interactions with mu-opioid agonists.
    Echo JA; Lamonte N; Christian G; Znamensky V; Ackerman TF; Bodnar RJ
    Brain Res; 2001 Dec; 921(1-2):86-97. PubMed ID: 11720714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.
    Giuliano C; Robbins TW; Nathan PJ; Bullmore ET; Everitt BJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2643-52. PubMed ID: 22805601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice.
    Zuberi AR; Townsend L; Patterson L; Zheng H; Berthoud HR
    Eur J Pharmacol; 2008 May; 585(1):14-23. PubMed ID: 18396272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central amygdala opioid transmission is necessary for increased high-fat intake following 24-h food deprivation, but not following intra-accumbens opioid administration.
    Parker KE; Johns HW; Floros TG; Will MJ
    Behav Brain Res; 2014 Mar; 260():131-8. PubMed ID: 24257074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens.
    Schad CA; Justice JB; Holtzman SG
    J Neurochem; 1996 Dec; 67(6):2292-9. PubMed ID: 8931460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-fat intake induced by mu-opioid activation of the nucleus accumbens is inhibited by Y1R-blockade and MC3/4R- stimulation.
    Zheng H; Townsend RL; Shin AC; Patterson LM; Phifer CB; Berthoud HR
    Brain Res; 2010 Sep; 1350():131-8. PubMed ID: 20346352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens.
    Zhang M; Gosnell BA; Kelley AE
    J Pharmacol Exp Ther; 1998 May; 285(2):908-14. PubMed ID: 9580643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB1 receptors modulate the intake of a sweetened-fat diet in response to μ-opioid receptor stimulation of the nucleus accumbens.
    Skelly MJ; Guy EG; Howlett AC; Pratt WE
    Pharmacol Biochem Behav; 2010 Nov; 97(1):144-51. PubMed ID: 20562021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective mu- and kappa-opioid receptor antagonists administered into the nucleus accumbens interfere with rapid tolerance to ethanol in rats.
    Varaschin RK; Morato GS
    Psychopharmacology (Berl); 2009 Sep; 206(1):85-96. PubMed ID: 19506836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mu-Opioid receptor stimulation in the nucleus accumbens elevates fatty tastant intake by increasing palatability and suppressing satiety signals.
    Katsuura Y; Heckmann JA; Taha SA
    Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R244-54. PubMed ID: 21543633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions.
    Ragnauth A; Ruegg H; Bodnar RJ
    Brain Res; 1997 Aug; 767(1):8-16. PubMed ID: 9365010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.